|
|
Volumn 314, Issue 7, 2015, Pages 657-659
|
|
Exploring statins to decrease HIV-related heart disease risk
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ATORVASTATIN;
CHOLESTEROL;
CYTOCHROME P450 3A4;
FLUORODEOXYGLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PITAVASTATIN;
PLACEBO;
ROSUVASTATIN;
ACUTE HEART INFARCTION;
ATHEROSCLEROTIC PLAQUE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
COHORT ANALYSIS;
CORONARY ARTERY ATHEROSCLEROSIS;
DRUG DOSE INCREASE;
DRUG GLUCURONIDATION;
DRUG METABOLISM;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
PATIENT SELECTION;
POSITRON EMISSION TOMOGRAPHY;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
SHORT SURVEY;
SMOKING;
T LYMPHOCYTE ACTIVATION;
TREATMENT OUTCOME;
CARDIOVASCULAR DISEASES;
COMPLICATION;
HYPERLIPIDEMIAS;
CARDIOVASCULAR DISEASES;
HIV INFECTIONS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 84940706996
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.5498 Document Type: Short Survey |
|
Times cited : (28)
|
|
References (0)
|